Skip to content

Study on the clinical application, norms, and standards of virtual reality rehabilitation training system for depression

Study on the clinical application, norms, and standards of virtual reality rehabilitation training system for depression

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052132
Enrollment
Unknown
Registered
2021-10-20
Start date
2021-10-18
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

experiment group:conventional emotional rehabilitation training + NeuCir-VR
control group:conventional emotional rehabilitation training + VR

Sponsors

Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the DSM-5 diagnostic criteria for major depressive episode or persistent depressive disorder; 2. Aged 18 to 65 years, male or female; 3. High school education level or above, with Chinese as the mother tongue; 4. There is sufficient audiovisual level to complete the necessary examinations for the study; 5. HAMD-17 score >=17 points at the time of enrollment.

Exclusion criteria

Exclusion criteria: 1. Those with severe systemic diseases such as cardiopulmonary disease who cannot tolerate rehabilitation treatment; 2. Diagnosed who meet the diagnostic criteria for other severe mental disorders, patients with epilepsy or those with a family history of epilepsy; 3. There are influencing factors of serious systemic diseases such as diabetes and uremia. 4. According to safety guidelines, there are contraindications to TMS and MRI examinations, such as: metal foreign bodies or other implanted electronic devices in the body; 5. Hearing or visual impairment may affect assessment and virtual reality rehabilitation; 6. Use of excitatory drugs that alter the cerebral cortex (anti-epileptic drugs, sedative-hypnotic drugs, etc.); 7. Those with severe negative suicidal ideation.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale-17;

Secondary

MeasureTime frame
Hamilton Anxiety Scale;Neuroelectrophysiological feedback and detection;functional magnetic resonance imaging (fMRI);mini-mental state examination;daily activities ability;

Countries

China

Contacts

Public ContactXu Jianguang

Shanghai University of Traditional Chinese Medicine

xjg@shutcm.edu.cn+86 21 51322091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026